Back to Search
Start Over
New Factor Xa Findings from National Cerebral and Cardiovascular Center Outlined (Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the Annexa-4 Study In Japan).
- Source :
- Clinical Trials Week; 10/3/2023, p237-237, 1p
- Publication Year :
- 2023
-
Abstract
- Osaka, Japan, Asia, Blood Coagulation Factors, Blood Proteins, Enzymes and Coenzymes, Factor Xa, Health and Medicine, Hematology, Peptide Hydrolases, Serine Endopeptidases Keywords: Osaka; Japan; Asia; Blood Coagulation Factors; Blood Proteins; Enzymes and Coenzymes; Factor Xa; Health and Medicine; Hematology; Peptide Hydrolases; Serine Endopeptidases EN Osaka Japan Asia Blood Coagulation Factors Blood Proteins Enzymes and Coenzymes Factor Xa Health and Medicine Hematology Peptide Hydrolases Serine Endopeptidases 237 237 1 10/03/23 20231003 NES 231003 2023 OCT 5 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss new findings in Proteins - Factor Xa. Keywords for this news article include: Osaka, Japan, Asia, Asia, Blood Coagulation Factors, Blood Proteins, Enzymes and Coenzymes, Factor Xa, Health and Medicine, Hematology, Japan, Peptide Hydrolases, Serine Endopeptidases, National Cerebral and Cardiovascular Center. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15436772
- Database :
- Complementary Index
- Journal :
- Clinical Trials Week
- Publication Type :
- Periodical
- Accession number :
- 172407375